Ginny Barbour
Born
Virginia M. Barbour
Alma materUniversity of Cambridge (MB BChir, MA)
University of Oxford (DPhil)
Scientific career
InstitutionsQueensland University of Technology
ThesisRegulation of the human α-globin genes by their chromatin context (1997)
Websitestaff.qut.edu.au/staff/ginny.barbour

Virginia M. Barbour is a professor at Queensland University of Technology in Brisbane, Australia, and serves as the Director of the Australasian Open Access Strategy Group.[1][2] She is best known for being one of the three founding editors of PLOS Medicine, and her various roles in championing the open access movement.[3][4]

Education

Barbour pursued a Bachelor of Medicine, Bachelor of Surgery (MB BChir) degree and Master of Arts (MA) degree at the University of Cambridge. This was followed by a Doctor of Philosophy degree in molecular medicine[5] at the University of Oxford where her research investigated the control of alpha globin genes and was awarded in 1997.[5][6]

Career and research

Following her education and training, Barbour served as an executive editor at The Lancet between 1994 and 2004.[3] Barbour was one of the three founding editors of PLOS Medicine (2004–2013), and later served as the PLOS Medicine Editorial Director (2012–2014), and the PLOS Medicine and Biology Editorial Director (2014–2015).[3][7] Barbour has also served as a chair of the Committee on Publication Ethics (COPE) for two terms (2012–2015; 2015–2017).[3][7][8][9] She serves as the director of the Australasian open access strategy group (2015–present), and works as a part-time professor between the Office of Research Ethics & Integrity and the Division of Technology, Information and Learning Services, at Queensland University of Technology in Brisbane, Australia.[3][6][7][8]

Barbour has published over 100 peer reviewed publications, generating over 14,000 citations and has an h-index of 20.[1][2] She has played a role in developing several reporting guidelines and open-access initiatives, including Consolidated Standards of Reporting Trials (CONSORT), Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), Healthcare Information For All (HIFA) and Evidence AID.[6]

Selected publications

  • Nephrotic syndrome associated with sulphasalazine[10]
  • UK Biobank: a project in search of a protocol?[11]
  • CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials[12]
  • CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. 2012. International Journal of Surgery.
  • Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide[13]
  • Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison[14]

References

  1. 1 2 Virginia Barbour publications indexed by Google Scholar
  2. 1 2 Virginia Barbour publications from Europe PubMed Central
  3. 1 2 3 4 5 Anon (2018). "Virginia Barbour: Queen of open access". BMJ. 363: k4148. doi:10.1136/bmj.k4148. ISSN 0959-8138. PMID 30355729. S2CID 53032870.
  4. ↑ Virginia Barbour on Twitter
  5. 1 2 Barbour, Virginia (1997). Regulation of the human α-globin genes by their chromatin context. jisc.ac.uk (DPhil thesis). University of Oxford. OCLC 43192909. EThOS uk.bl.ethos.244591.
  6. 1 2 3 "QUT | Staff Profiles | Ginny Barbour". staff.qut.edu.au. Retrieved 19 May 2019.
  7. 1 2 3 Tachibana, Chris (3 November 2017). "Responsibly conducting research". Science | AAAS. Retrieved 19 May 2019.
  8. 1 2 Couzin-Frankel, Jennifer (2018). "'Journalologists' use scientific methods to study academic publishing. Is their work improving science?". Science. doi:10.1126/science.aav4758. ISSN 0036-8075. S2CID 115360831.
  9. ↑ "Virginia Barbour | Committee on Publication Ethics: COPE". publicationethics.org. Retrieved 19 May 2019.
  10. ↑ Barbour, V M; Williams, P F (1990). "Nephrotic syndrome associated with sulphasalazine". BMJ. 301 (6755): 818. doi:10.1136/bmj.301.6755.818-b. ISSN 0959-8138. PMC 1663947. PMID 1977483.
  11. ↑ Barbour, Virginia (2003). "UK Biobank: a project in search of a protocol?". The Lancet. 361 (9370): 1734–1738. doi:10.1016/S0140-6736(03)13377-6. ISSN 0140-6736. PMID 12767753. S2CID 37182739.
  12. ↑ Schulz, Kenneth F.; Altman, Douglas G.; Moher, David; the CONSORT Group (24 March 2010). "CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials". BMC Medicine. 8 (1): 18. doi:10.1186/1741-7015-8-18. ISSN 1741-7015. PMC 2860339. PMID 20334633.
  13. ↑ Hoffmann, T. C.; Glasziou, P. P.; Boutron, I.; Milne, R.; Perera, R.; Moher, D.; Altman, D. G.; Barbour, V.; Macdonald, H.; Johnston, M.; Lamb, S. E.; Dixon-Woods, M.; McCulloch, P.; Wyatt, J. C.; Chan, A.-W.; Michie, S. (2014). "Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide". BMJ. 348 (mar07 3): g1687. doi:10.1136/bmj.g1687. hdl:10072/66804. ISSN 1756-1833. PMID 24609605.
  14. ↑ Shamseer, Larissa; Moher, David; Maduekwe, Onyi; Turner, Lucy; Barbour, Virginia; Burch, Rebecca; Clark, Jocalyn; Galipeau, James; Roberts, Jason; Shea, Beverley J. (2017). "Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison". BMC Medicine. 15 (1): 28. doi:10.1186/s12916-017-0785-9. ISSN 1741-7015. PMC 5353955. PMID 28298236.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.